Does Smoking Cause Visceral Fat? Risks Explained

Smoking and visceral fat are more closely linked than many people realise. Research consistently shows that smokers tend to accumulate greater amounts of visceral fat, the deep abdominal fat surrounding organs such as the liver and pancreas, even when their overall body weight is lower than that of non-smokers. This pattern raises serious metabolic and cardiovascular risks that are not always visible from the outside. Understanding how smoking drives visceral fat accumulation, what this means for long-term health, and how to reduce abdominal fat after quitting can help people make informed decisions about their health.

Does smoking cause visceral fat to build up around your organs?

Yes, smoking promotes visceral fat accumulation through cortisol dysregulation, insulin resistance and sympathetic nervous system activation, even in smokers who weigh less than non-smokers.

Yes, smoking is associated with increased visceral fat accumulation, even in people who weigh less overall than non-smokers. Visceral fat is the metabolically active fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines. Unlike subcutaneous fat, which sits just beneath the skin, visceral fat is strongly linked to metabolic and cardiovascular disease.

Research consistently shows that smokers tend to carry a greater proportion of their body fat in the abdominal region compared with non-smokers of similar body weight.^[13] This pattern is sometimes described as a central or android fat distribution. The mechanisms are not fully understood, but several biological pathways are thought to contribute:

• Cortisol dysregulation: Nicotine is thought to stimulate the release of cortisol, a stress hormone that may promote fat redistribution towards the abdomen.^[1][2]

• Insulin resistance: Smoking appears to impair insulin sensitivity, which may encourage the body to store energy as visceral fat rather than using it efficiently.^[2][3]

• Appetite suppression: Nicotine suppresses appetite, meaning smokers may weigh less overall while still carrying disproportionately high levels of harmful abdominal fat.

• Sympathetic nervous system activation: Nicotine activates the sympathetic nervous system, which may alter fat metabolism and storage patterns.^[4][19]

It is important to note that a lower body weight does not protect against the metabolic harms of visceral fat. A smoker who appears slim may still carry clinically significant levels of visceral fat, placing them at elevated risk of conditions such as type 2 diabetes and cardiovascular disease. This makes smoking a particularly concerning contributor to metabolic risk, as the danger is not always visible.

Clinicians estimate visceral adiposity using waist circumference or waist-to-height ratio rather than body weight or BMI alone. NICE obesity guidance recommends waist circumference measurement alongside BMI, with action thresholds that vary by sex and ethnicity. As a general guide, a waist-to-height ratio above 0.5 is considered a marker of increased metabolic risk in most adults. If you are concerned, a GP can carry out a full assessment.

How does visceral fat affect your long-term health risks?

Excess visceral fat raises the risk of type 2 diabetes, cardiovascular disease and liver disease by releasing inflammatory substances directly into the portal circulation, disrupting glucose and lipid metabolism.

Excess visceral fat significantly raises the risk of serious long-term health conditions, including type 2 diabetes, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease or NAFLD) and certain cancers. Unlike subcutaneous fat, visceral fat is metabolically active and releases inflammatory cytokines, free fatty acids and hormones directly into the portal circulation, which drains into the liver.^[10][11] This creates a sustained inflammatory environment that damages blood vessels, disrupts glucose metabolism and impairs liver function over time.

From a cardiovascular perspective, visceral fat is associated with raised triglycerides, reduced HDL (good) cholesterol and elevated blood pressure, all of which contribute to atherosclerosis.^[3][10] NICE obesity guidance and NHS cardiovascular risk resources recognise central adiposity as a clinically important risk factor, and waist circumference is used alongside BMI in clinical practice to identify people at elevated metabolic risk. NICE recommends waist circumference thresholds that vary by sex and ethnicity: for example, a waist circumference above 94 cm in most men (80 cm in most women) indicates increased risk, with higher thresholds used for some South Asian populations where risk increases at lower measurements.^[7][9] A GP can advise on the appropriate threshold for an individual.

Visceral fat also plays a role in the development of type 2 diabetes by promoting insulin resistance in the liver and skeletal muscle. The free fatty acids released by visceral fat interfere with insulin signalling, making it harder for cells to take up glucose effectively. Over time, this places increasing demand on the pancreas and can lead to beta-cell exhaustion.

For people who smoke, the combination of nicotine-driven cortisol elevation, insulin resistance and visceral fat accumulation creates a compounding risk profile. Stopping smoking remains one of the most effective steps a person can take to reduce overall cardiovascular and metabolic risk, even if short-term changes in body composition occur during the cessation period.

Does quitting smoking make visceral fat worse before it gets better?

Quitting smoking can temporarily increase abdominal fat in the first six to twelve months due to increased appetite and a lower resting metabolic rate, but long-term cessation improves metabolic health overall.

Quitting smoking can lead to a temporary increase in total body fat, including visceral fat, in the months immediately following cessation, though this effect is generally outweighed by the long-term health benefits of stopping. Studies have observed that people who stop smoking often gain weight in the first six to twelve months, with some of this gain occurring in the abdominal region.^[21] This can be discouraging, but it is important to understand the underlying reasons and the broader context.

Several factors contribute to post-cessation weight and fat changes:

• Increased appetite: Nicotine suppresses appetite by acting on hypothalamic pathways.^[21] When nicotine is removed, appetite typically increases, leading to higher calorie intake.

• Reduced metabolic rate: Nicotine has a mild thermogenic effect, slightly raising the resting metabolic rate.^[17][18] Cessation removes this effect, meaning the body burns fewer calories at rest.

• Behavioural substitution: Some people replace the habit of smoking with eating, particularly foods high in sugar or fat.

• Stress eating: Withdrawal symptoms and psychological stress during cessation can trigger emotional eating.

However, research suggests that over the longer term, people who successfully quit smoking tend to see improvements in metabolic markers, including reductions in visceral fat relative to those who continue smoking. The cardiovascular and metabolic benefits of cessation far exceed the risks associated with modest post-cessation weight gain.

NICE tobacco dependence guidance (NG209) recommends a range of evidence-based cessation treatments, including nicotine replacement therapy (NRT), varenicline, bupropion and licensed nicotine vaping products, alongside behavioural support.^[14][15] NHS Stop Smoking Services offer free, personalised support and can help address weight management concerns as part of a comprehensive cessation plan, rather than allowing fear of weight gain to deter someone from quitting. You can find your nearest service through the NHS website.

What does the evidence say about smoking, weight, and belly fat?

Evidence from cohort studies and meta-analyses shows smokers have higher waist-to-hip ratios and greater visceral fat volumes than non-smokers, even at lower BMI, with heavier smokers showing more pronounced central adiposity.

The evidence consistently shows that smoking promotes central fat distribution, meaning smokers tend to accumulate more belly fat relative to their total body weight compared with non-smokers. Large observational cohort studies and meta-analyses have found that current smokers have higher waist-to-hip ratios and greater visceral fat volumes on imaging, even when their overall BMI is lower than that of non-smokers.^[13]

One important finding from this evidence base is that the relationship between smoking and visceral fat appears to be dose-dependent: heavier smokers tend to show more pronounced central adiposity than lighter smokers. This suggests that the biological mechanisms thought to drive visceral fat accumulation, including cortisol elevation and insulin resistance, may be related to the degree of nicotine and tobacco exposure.

It is also worth noting that the evidence distinguishes between total body fat and fat distribution. Smoking may reduce total body weight through appetite suppression and increased metabolic rate, but it simultaneously shifts fat storage towards the visceral compartment. This means that relying on body weight or BMI alone to assess metabolic risk in smokers is insufficient.

From a clinical perspective, waist circumference measurement is a more informative tool for identifying visceral fat risk in this population. NICE obesity guidance recommends waist circumference thresholds as part of metabolic risk assessment, with action levels varying by sex and ethnicity. As a practical guide, a waist-to-height ratio above 0.5 is widely used as a simple screening measure. For people concerned about their weight and metabolic health, a GP can provide a full assessment. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options may be discussed.

How can you reduce visceral fat after stopping smoking?

Visceral fat can be reduced after quitting smoking through at least 150 minutes of weekly aerobic exercise, a diet rich in fibre and lean protein, reduced alcohol intake, and improved sleep and stress management.

Reducing visceral fat after stopping smoking is achievable through a combination of dietary changes, regular physical activity and, where appropriate, clinical support. Visceral fat is generally more responsive to lifestyle intervention than subcutaneous fat, meaning targeted changes can produce meaningful results relatively quickly.

Physical activity is one of the most effective tools for reducing visceral fat. Aerobic exercise, such as brisk walking, cycling or swimming, has evidence supporting reductions in abdominal fat even without significant changes in total body weight.^[24][25] NHS guidelines for adults recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days per week.^[22] These guidelines are published on the NHS website.

Dietary adjustments that support visceral fat reduction include:

• Reducing intake of foods high in fat, salt and sugar, in line with the NHS Eatwell Guide

• Increasing dietary fibre from vegetables, legumes and wholegrains

• Prioritising lean protein sources to support satiety and muscle maintenance

• Limiting alcohol intake; the UK Chief Medical Officers advise keeping consumption to no more than 14 units per week, spread across several days, as alcohol contributes independently to weight gain including in the abdominal region^[23]

Sleep and stress management are clinically relevant factors. Poor sleep and chronic stress are both associated with elevated cortisol, which is thought to drive visceral fat storage. Addressing these factors alongside diet and exercise may improve outcomes.

A waist-to-height ratio above 0.5, or a waist circumference above the thresholds recommended in NICE obesity guidance, can serve as a practical measure to monitor progress over time. A GP can advise on appropriate targets for an individual.

For people with obesity or significant metabolic risk, NICE-recommended weight management interventions, including structured programmes and, in some cases, pharmacological treatment, may be appropriate. A GP can assess eligibility and refer to specialist services where needed. NHS Stop Smoking Services also offer ongoing support that can be combined with weight management advice, helping people address both concerns simultaneously rather than treating them as competing priorities.

Scientific References

1. Stress-induced cortisol response and fat distribution in women.
2. The regulation of adipose tissue distribution in humans.
3. Visceral obesity: a 'civilization syndrome'.
4. Nicotine improves obesity and hepatic steatosis and ER stress.
5. Keep the size of your waist to less than half of your height – NICE recommends.
6. Calculate your waist to height ratio.
7. Overweight and obesity management (NG246): Identifying and assessing overweight, obesity and central adiposity.
8. Overweight and obesity management (NG246).
9. Appendix A1: Summary of evidence from surveillance (NG246).
10. Visceral fat and metabolic inflammation: the portal theory revisited.
11. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors.
12. The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD.
13. Smoking associates with visceral fat accumulation especially in women. Circulation Journal.
14. Treating tobacco dependence (NG209).
15. Smoking cessation – treatment summaries.
16. Quit smoking with nicotine-free medicines – Better Health.
17. Acute effects of nicotine on resting metabolic rate in cigarette smokers.
18. Metabolic effects of nicotine after consumption of a meal in smokers and nonsmokers.
19. Effect of nicotine on norepinephrine turnover and thermogenesis in brown adipose tissue and metabolic rate in MSG obese mice.
20. Effects of body mass on nicotine-induced thermogenesis and catecholamine release in male smokers.
21. A mouse model of weight gain after nicotine withdrawal.
22. Physical activity guidelines for adults aged 19 to 64.
23. Alcohol consumption: advice on low risk drinking – UK Chief Medical Officers' guidelines.
24. A dose-response relation between aerobic exercise and visceral fat reduction.
25. Aerobic exercise and weight loss in adults: a systematic review.

Frequently Asked Questions